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Hydrates are technologically important and ubiquitous yet they remain a poorly
understood and understudied class of molecular crystals. In this work, we
attempt to rationalize propensity towards hydrate formation through crystal-
lization studies of molecules that lack strong hydrogen-bond donor groups. A
Cambridge Structural Database (CSD) survey indicates that the statistical
occurrence of hydrates in 124 molecules that contain five- and six-membered N-
heterocyclic aromatic moieties is 18.5%. However, hydrate screening experi-
ments on a library of 11 N-heterocyclic aromatic compounds with at least two
acceptor moieties and no competing hydrogen-bond donors or acceptors reveals
that over 70% of this group form hydrates, suggesting that extrapolation from
CSD statistics might, at least in some cases, be deceiving. Slurrying in water and
exposure to humidity were found to be the most effective discovery methods.
Electrostatic potential maps and/or analysis of the crystal packing in anhydrate
structures was used to rationalize why certain molecules did not readily form
hydrates.
1. Introduction
Hydrates represent a type of multicomponent crystals that are
ubiquitous thanks to the presence of moisture in most crys-
tallization reactions. That there is general interest in hydrates
is reflected in the increasing number of publications on crys-
talline hydrates in areas such as pharmaceutical and materials
sciences. Indeed, water is the most common solvent included
in molecular crystals even if present adventitiously (Desiraju,
1991; Go¨rbitz & Hersleth, 2000). The existence of hydrates has
been rationalized based on the following features of a water
molecule: (i) small size; (ii) tendency to form multidirectional
hydrogen bonds with itself as well as other compounds; (iii)
ability to serve as a donor and/or acceptor for up to two
hydrogen bonds (Desiraju, 1991). The study of hydrates is of
particular significance in the context of the pharmaceutical
industry (Khankari & Grant, 1995; Vippagunta et al., 2001;
Trask et al., 2006; Eddleston et al., 2014; Madusanka et al.,
2014) since hydrate formation can alter the physicochemical
properties of a drug substance, sometimes positively (Morris,
1999). Indeed, a hydrate is the selected solid form for several
commercial drug substances (Lee et al., 2011), e.g. cefadroxil
(monohydrate) (Bouzard et al., 1985), paroxetine hydro-
chloride (hemihydrate) (Barnes et al., 1988), cephalexin
(monohydrate) (Horatius, 1975), ampicillin (trihydrate)
(Bahal, 1975), cromolyn sodium (disodium cromoglycate, non-
stoichiometric hydrates) (Chen et al., 1999) and nitrofurantoin
(monohydrate) (Cazer et al., 1994). Further, up to 33% of
entries in the European Pharmacopeia (1991) are reported to
exist as hydrates (Henck et al., 1997). Water, being a non-toxic
solvent, does not typically raise any serious regulatory
concerns when it is present in a drug substance. However, in
materials science, its presence, be it in trace amounts or in
larger quantities, can affect the outcome of a reaction and/or
negatively impact stability or performance. For example, many
metal–organic materials (MOMs) degrade in the presence of
water vapor (Ming et al., 2015). Further, water vapor can
diminish the gas sorption performance of physisorbents
(Kumar et al., 2015). However, this does not mean that the
existence of hydrates is predictable or well understood.
Indeed, we have suggested that the promiscuity of water
makes it a nemesis of crystal engineering (Clarke et al.,
2010).
From a crystal engineering (Pepinsky, 1955; Schmidt, 1971;
Desiraju, 1989; Moulton & Zaworotko, 2001) perspective,
hydrates raise the following questions, amongst others: (i)
Can one pre-determine whether or not a given organic
compound is predisposed to form hydrate(s)? (ii) In
general, how common is hydrate formation for molecular
organic compounds? (iii) What are the most effective
experimental methods for the discovery of hydrates?
Several research groups have examined the statistical
frequency of occurrence of crystalline hydrates (Infantes et al.,
2007), conditions for their formation (Khankari & Grant,
1995; Morris, 1999; Infantes et al., 2007) and preferred
chemical environments for water molecules (Gillon
et al., 2003; Infantes et al., 2003; Hickey et al., 2007).
Statistical analyses typically rely on the Cambridge Structural
Database (CSD) (Allen & Kennard, 1993; Allen, 2002),
which contains almost one million structures and is a
broad enough dataset for some if not most statistical studies.
However, as we discuss herein the CSD is not a panacea
for all queries related to crystal engineering. Additionally,
software-based limitations are a general concern (Infantes
& Motherwell, 2002; Mascal et al., 2006; van de Streek
& Motherwell, 2007). In particular, the types of crystal
structures in the CSD can only serve as a backwards leaning
representation of experimental outcomes, i.e. they are reflec-
tive of the types of molecules that were of interest in the past
and are not necessarily representative of the full diaspora of
molecular compounds. Further, with respect to hydrates in
particular, the crystal structures reported in the CSD are not
necessarily a result of systematic experiments aimed at
hydrates and the CSD lacks experimental details about crys-
tallization. For example, systematic screening experiments
aimed at hydrates such as those undertaken routinely in
pharmaceutical science (Grant & Higuchi, 1990; Griesser,
2006; Guillory, 1999; Morris, 1999; Zhu & Grant, 1996; Zhu,
1996) are rarely reported in the scientific literature (Newman
& Wenslow, 2016).
Solvates, including hydrates, have been classified as two
main types: stoichiometric and non-stoichiometric (Griesser,
2006). Based on their structural attributes, hydrates have been
further classified into three categories: (i) channel hydrates;
(ii) isolated site hydrates; (iii) metal ion associated hydrates
(Morris & Rodriguez-Hornedo, 1993). As far as stoichiometric
hydrates are concerned, attempts have been made to provide a
rational basis for incorporation of water of hydration in
crystals. Hypotheses such as propensity being linked to
imbalance in the ratio of hydrogen-bond donors and acceptors
(Desiraju, 1991) or the sum of and/or difference in the total
number of hydrogen-bond donors and acceptors (Infantes et
al., 2007) have been advanced. These are largely in accordance
with Etter’s hydrogen-bonding rule, which states that ‘all good
proton donors and acceptors are used in hydrogen bonding’
(Etter, 1990). In this context, the identification of eight
different environments for water by Gillon et al. is noteworthy
(Gillon et al., 2003). Most frequently, water serves as a donor
of two hydrogen bonds and an acceptor of one hydrogen bond,
and it has been suggested that the water environment corre-
lates with the ratio of hydrogen-bond donors/acceptors in the
molecular compound studied (Infantes et al., 2007). Incor-
poration of water molecules in the crystal lattice is presumed
to provide alternative modes of crystal packing through water-
mediated supramolecular heterosynthons (Clarke et al., 2010;
Walsh et al., 2003). Computational and statistical models have
also been used to rationalize hydrate formation (Hulme &
Price, 2007; Price, 2008; Braun et al., 2011; Takieddin et al.,
2016). Electrostatic potential has been shown to be an effec-
tive indicator to predict the hydrate propensity in certain types
of molecules (Murray et al., 1991; Murray & Politzer, 1991;
Galabov et al., 2003). These studies have thus far been limited
to specific molecules. However, despite much progress, the
formation of hydrates still remains largely unpredictable and
represents a challenge in crystal engineering (Clarke et al.,
2010).
In previous reports, we demonstrated that a tetrafunctional
molecular cluster, [{M(CO)3(3-OH)}4] (M = Mn or Re), can
serve as a strong hydrogen-bond donor to form solvates,
hydrates or cocrystals (Clerk & Zaworotko, 1991; Copp et al.,
1992, 1993, 1995), even with molecules that serve as only weak
hydrogen-bond acceptors such as arenes (Copp et al., 1995).
Notably, [{M(CO)3(3-OH)}4] can only be crystallized from
solution as a single-component crystal if a dried distilled
solvent such as CHCl3 is used (Holman & Zaworotko, 1995).
This is unsurprizing in the context of a subsequent CSD
analysis, which suggested that unsatisfied hydrogen-bond
donors might be the main driving force for hydrate formation
(Infantes et al., 2003). The corollary of this is that a high ratio
of hydrogen-bond donors/acceptors would be expected to
result in high propensity to form hydrates, as has been
suggested by van de Streek and Motherwell (van de Streek &
Motherwell, 2007). In this contribution, we examine the
propensity for hydrate formation at one extreme through a
CSD and experimental study. Specifically, we focus upon five-
and six-membered N-heterocyclic aromatic compounds that
contain two or more hydrogen-bond acceptors but are devoid
of strong hydrogen-bond donors. Our experimental data
were collected for a library of 11 molecular compounds
(Fig. 1).
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2. Experimental
2.1. General aspects
All reagents and solvents were purchased from Sigma–
Aldrich, Alfa Aesar or AK scientific, and used as received. 1H
and 13C Nuclear Magnetic Resonance (NMR) spectra were
recorded on a Jeol EX270. Powder X-ray diffraction (PXRD)
data were collected using a Philips X’Pert PRO MPD
equipped with a Cu K source. Data were collected from 5 to
40 2, using a step size of 0.02 at a scan rate of 0.1 min1.
Thermogravimetric Analyses (TGA) were measured on a TA
Instruments Q50 TG from ambient temperature to 500C
under a 60 ml min1 flow of N2, at a scan rate of 20C min
1.
Karl Fisher titrations (volumetric) were performed on a
Mettler DL31; Fisher Aqualine, Solvent K/2100/15 and titrant
K/2000/15 were used as two- and single-component reagents,
respectively. Karl Fischer titrations were performed at 15–
20% R.H. and 27C.
2.2. X-ray crystallography
X-ray diffraction data for 2, 62H2O and 9 were collected at
100 (2) K, while data for 74H2O were collected at 273 (2) K,
under N2 flow, on a Bruker Quest D8 Mo Sealed Tube
equipped with CMOS camera and Oxford cryosystem with
Mo K radiation ( = 0.71073 A˚). Data for 3, 6, 102H2O and
113H2O were collected at 100 (2) K, under N2 flow, on a
Bruker Quest D8 Cu Microfocus with Cu K radiation ( =
1.5418 A˚). Indexing and data reduction were conducted using
the Bruker APEX2 suite (Bruker, 2010) (Difference Vectors
method) and corrected for absorption using the multi-scan
method implemented in Bruker SADABS software (Shel-
drick, 2008b). All structures were solved by direct methods
(SHELXS97), and refined (SHELXL97) by full least-squares
on all F2 data (Sheldrick, 2008a; Spek, 1990). All non-H atoms
were refined anisotropically. H atoms were placed in calcu-
lated positions, with the exception of those on water mole-
cules, which were refined after location from inspection of the
electron density map. In 113H2O the H atoms of some of the
water molecules could not be located and the O atoms were
refined as isolated atoms. Crystallographic data and refine-
ment parameters for all structures are given in Table 1.
2.3. Syntheses of compounds
Compounds 1, 4, 5 and 8 were purchased from Sigma
Aldrich and used as received. Compounds 2, 3 and 6 were
prepared by Pd0-catalyzed Sonogashira coupling of 4-ethy-
nylpyridyine hydrochloride with the corresponding mono- or
diiodo derivatives (4-iodopyridine, 1,4-diiodobenzene and
4,40-diiodobiphenyl, respectively). Compound 7 was synthe-
sized by condensation of 4-pyridylcarboxaldehyde and 1,4-
diaminobenzene by refluxing in dry EtOH based on a proce-
dure reported in the literature (Sek et al., 2013). Compounds 9
and 10 were synthesized by twofold Pd0-catalyzed Suzuki
cross-coupling of 4-pyridynylboronic acid with 1,4-dibromo-
benzene and 1,4-dibromodurene, respectively. Compound 11
was obtained by following a previously reported nucleophilic
substitution on cyanuric chloride with imidazole under solvent
free conditions (Azarifar et al., 2004). The molecular structure
of each compound was confirmed by 1H and 13C NMR spec-
troscopies and SCXRD. Detailed accounts of the syntheses of
compounds 2, 3, 6, 9, and 10 are given in the supporting
information.
2.4. Single crystals
1,2-Bis(4-pyridyl)acetylene (2). Prism-shaped crystals of 2
were obtained via slow evaporation of a solution of 2 (20 mg,
0.11 mmol) in 4 ml of toluene over 3 d (yield 19 mg).
4,40-Bis(4-ethynylpyridyl)biphenyl (3). Needle-shaped
crystals of 3 were obtained by slow evaporation of a solution
of 3 (25 mg, 0.07 mmol) in 5 ml of MeOH over 5 d (yield
15 mg).
1,4-Bis(4-ethynylpyridyl)benzene (6). Plate-shaped crystals
of the anhydrous form of 6 were obtained by slow evaporation
of a solution of 6 (30 mg, 10.7 mmol) in 4 ml of toluene over
10 d (yield 20 mg).
1,4-Bis(4-ethynylpyridyl)benzene (62H2O). Cubic crystals
of the dihydrate of 6 were obtained by slow evaporation of a
solution of 6 (30 mg, 10.7 mmol) in 4 ml of MeOH/H2O
mixture (1:1 v/v) over 6 d (yield 12 mg).
Bis(pyridin-4-ylmethylene)benzene-1,4-diamine tetra-
hydrate (74H2O). Plate-like crystals of the tetrahydrate of 7
were obtained by slow evaporation of a saturated solution of 7
(30 mg, 0.10 mmol) in 5 ml of ethanol over a period of 5 d
(yield 8 mg).
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Figure 1
The library of N-heterocyclic compounds investigated herein for hydrate
formation. Refcodes for those anhydrates (Anh) and hydrates (H2O)
reported in the CSD are given. Previously unreported structures are
denoted as ‘New’. The stoichiometry of water in hydrated structures is
given in parentheses.
1,4-Bis(4-pyridyl)durene (9). Cubic crystals of 9 were
obtained by slow evaporation of a solution of 9 (25 mg,
0.09 mmol) in 5 ml of EtOH over 2 weeks (yield 19 mg).
1,4-Bis(4-pyridyl)benzene dihydrate (102H2O). Needle-
shaped crystals of 102H2O were obtained by slow evaporation
of a solution of 10 (25 mg, 0.11 mmol) in 5 ml of ethyl acetate
over 5 d (yield 24 mg).
2,4,6-Tris(imidazol-1-yl)-1,3,5-s-triazine (113H2O).
Column-shaped crystals of the trihydrate of 11 were obtained
by slow evaporation of 11 (30 mg, 0.11 mmol) in 3 ml of ethyl
acetate over 5 d (yield 12 mg).
2.5. Slurry experiments
50 mg of compound was slurried in a solvent system
acceptable for use in the pharmaceutical industry in a sealed
glass vial at room temperature. The volume of solvent used
was one-third of the volume required to dissolve the sample
completely. Aliquots of sample were removed after 1, 2, 4, 5
and 7 d in order to record the PXRD patterns.
2.6. Stability
To determine stability under ambient conditions, samples
were exposed to the laboratory atmosphere. PXRD data were
recorded after 1, 3, 7, 10 and 30 d. Stability to humidity was
evaluated by placing 50 mg of each sample in a humidity
chamber under 75% relative humidity (R.H.) at 40C.
Aliquots were removed from the chamber after 6, 7, 10, 12 and
14 d and PXRD data were collected on each aliquot.
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Table 1
Crystal data and refinement details.
Compound 2 3 6 62H2O
Chemical formula C12H8N2 C26H16N2 C20H12N2 C20H16N2O2
Mr 180.20 356.41 280.32 316.35
T (K) 100 (2) 100 (2) 100 (2) 100 (2)
Crystal system Orthorhombic Monoclinic Orthorhombic Monoclinic
Space group Fddd P21/c Pna21 P21/c
Z 8 2 4 2
a (A˚) 9.2584 (18) 22.1029 (5) 17.7436 (16) 14.957 (3)
b (A˚) 12.936 (2) 5.62770 (10) 10.8510 (11) 4.8702 (9)
c (A˚) 15.764 (3) 7.5548 (2) 7.5217 (7) 11.199 (2)
 () 90 90 90 90
 () 90 99.7070 (10) 90 103.719 (5)
 () 90 90 90 90
V (A˚3) 1888.0 (6) 926.28 (4) 1448.2 (2) 792.5 (3)
Dx (Mg m
3) 1.268 1.285 1.286 1.326
 (mm1) 0.077 0.582 0.594 0.087
Measured/independent reflections (Rint) 7024/664 (0.0772) 10 730/1625 (0.0179) 5947/2014 (0.1841) 10 327/1836 (0.1131)
Observed reflections [I > 2(I)] 478 1317 1112 1014
R1†, wR2‡ [I > 2(I)] 0.0812, 0.2058 0.0464, 0.1436 0.0685, 0.1328 0.0784, 0.1254
R1, wR2 (all data) 0.1183, 0.2284 0.0548, 0.1519 0.1506, 0.1629 0.1676, 0.1498
	min, 	max (e A˚
3) 0.304, 0.390 0.734, 0.184 0.250, 0.241 0.34, 0.274
Goodness-of-fit on F2 1.144 1.098 1.011 1.070
Compound 74H2O 9 102H2O 113H2O
Chemical formula C18H22N4O4 C20H20N2 C16H16N2O2 C24H24N18O5.5
Mr (g mol
1) 358.39 288.38 268.31 652.61
T (K) 273 (2) 100 (2) 100 (2) 100 (2)
Crystal system Triclinic Orthorhombic Monoclinic Monoclinic
Space group P1 Pna21 P21/c C2/c
Z 1 4 2 8
a (A˚) 7.7923 (9) 21.105 (4) 7.4431 (4) 38.9915 (11)
b (A˚) 7.9651 (9) 6.5848 (11) 3.9111 (2) 6.9971 (2)
c (A˚) 8.4455 (10) 11.241 (2) 22.7679 (12) 29.1584 (9)
 () 102.627 (3) 90 90 90
 () 95.961 (3) 90 99.239 (4) 130.424 (2)
 () 114.174 (3) 90 90 90
V (A˚3) 455.51 (9) 1562.2 (5) 654.19 (6) 6056.0 (3)
	calc (g cm
3) 1.307 1.226 1.362 1.432
 (mm1) 0.094 0.072 0.735 0.919
Measured/independent reflections (Rint) 6294/2134 (0.0422) 37 588/3625 (0.1743) 6041/1261 (0.1050) 37 075/5171 (0.0859)
Observed reflections [I > 2(I)] 1325 2466 876 4014
R1†, wR2‡ [I > 2(I)] 0.1018, 0.1549 0.0745, 0.1295 0.0888, 0.1820 0.0536, 0.1288
R1, wR2 (all data) 0.1665, 0.1736 0.1286, 0.1467 0.1322, 0.2074 0.0744, 0.1407
	min, 	max (e A˚
3) 0.348, 0.217 0.280, 0.456 0.439, 0.652 0.555, 0.991
Goodness-of-fit on F2 1.134 1.065 1.066 1.036
† R1 =
P
||Fo|  |Fc||/
P
|Fo|. ‡ wR2 = {
P
[w(Fo
2
P
Fc
2)2]/
P
[w(Fo
2)]}1/2.
2.7. Solvent drop grinding (SDG)
20 mg of anhydrous sample was placed in an agate mortar
and 10 mL of water was added. Mild hand grinding with a
pestle was conducted until the initial paste became a fine
powder (ca. 10 min). The sample was then characterized by
PXRD and TGA.
2.8. Electrostatic potential map calculations
The atomic positions of the molecules of compounds 1–11
were fully optimized using second-order Møller–Plesset
perturbation theory (MP2) (Møller & Plesset, 1934) with the
6-31G* basis set applied to all atoms. The optimization
calculations were performed with the NWChem ab initio
simulation software (Valiev et al., 2010). For each compound, a
three-dimensional surface around the molecule was calcu-
lated, where the electron density was equal to 0.002 a.u. The
resulting isodensity surface served as the basis for mapping the
electrostatic potential. The electrostatic potential of the
respective molecules was then calculated using density func-
tional theory (DFT) with the 6-31G* basis set for all atoms
and with the M06 hybrid functional (Zhao & Truhlar, 2008). A
graphical representation (map) of the electrostatic potential
surface for each molecule was generated using Spartan ’14
software (Wavefunction, 2014).
3. Results and discussion
3.1. CSD analysis
The CSD (ConQuest 1.18, CSD v5.37 + 1 November 2015
update (Bruno et al., 2002), only organics, three-dimensional
coordinates determined and R  0.075; Group I and II
elements were excluded) contains 257 442 entries that would
be classified as molecular organic crystal structures. Of these,
16 710 (6.5%) were found to contain water molecules. We
focused our analysis upon molecules containing only
hydrogen-bond acceptors, specifically five- and six-membered
N-heterocyclic aromatic rings: pyridyl, pyrimidyl, pyrrolyl and
R-imidazoyl moieties, Fig. S1. Compounds with ortho-substi-
tuents were excluded to eliminate any bias caused by steric
effects. A total of 4962 hits were retrieved as hitlist 1 (Fig. S1).
Of these, 564 entries (11.4%, hitlist 2) contain one or more
water molecules and 288 (hitlist 3) contain a neutral organic
molecule and at least one water molecule in the asymmetric
unit. The remaining 276 entries are multicomponent systems
containing water. In hitlist 3, water molecules were observed
to most commonly hydrogen bond to aromatic nitrogen atoms
(197 entries). Other moieties found to interact with water
molecules include amido (98 entries), primary and secondary
amino (29 entries), hydroxyl (10 entries) and/or carboxyl
groups (7 entries).
Hitlist 1 (4962 entries) was further restricted by excluding
molecular compounds containing competing hydrogen-bond
donor and acceptor groups (Fig. S1). Entries with hydrogen-
bond donors such as primary and secondary amino, imino,
hydroxyl, carboxyl, hydroxysulfonyl and thio were thereby
excluded. Likewise, compounds with hydrogen-bond accep-
tors such as amido, imino, hydroxyl, carboxyl, alkoxy,
alkoxycarbonyl/aryloxycarbonyl, carbonyl, nitro, cyano and
halo were excluded, resulting in hitlist 4 (482 entries). Hitlist 4
was examined manually and those entries containing alkyl
chains with more than three C atoms were eliminated, as were
those with fused aromatic rings larger or equivalent in size to
anthracene/phenanthrene. These exclusions addressed the
potential influence of large aliphatic/aromatic moieties on
crystal packing. The number of entries was thereby reduced to
139 (hitlist 5). To determine how many individual organic
molecules remained, we removed duplicates, polymorphs and
hydrates. At this point, 124 unique compounds remained
(hitlist 6), of which 23 (or 18.5%) are known to form hydrates
(hitlist 7).
The above statistics indicate that the propensity to form
hydrates for this class of hydrogen-bond acceptors is impacted
by competing hydrogen-bonding functional groups: ca. 11.4%
of the hits are hydrates in a competitive environment whereas
ca. 18.5% of the entries are hydrates in a non-competitive
environment. The propensity for hydrate formation discerned
from our statistical analysis using the refined data correlates
well with that previously reported for molecular compounds
with sp2-hybridized nitrogen atoms (ca. 16.8%) (Infantes et al.,
2003). However, is 16.8% an indication of the general
propensity for this class of compounds? In order to address
this matter we conducted a series of hydrate screening
experiments.
3.2. Hydrate screening experiments
We selected a library of five- and six-membered N-hetero-
cyclic aromatic compounds, developed as part of our ongoing
research into crystal engineering of MOMs and hybrid ultra-
microporous materials (Subramanian & Zaworotko, 1995;
Burd et al., 2012; Nugent et al., 2013a,b; Scott et al., 2015; Chen
et al., 2015; Cui et al., 2016), as representative of molecules
which contain only strong hydrogen-bond acceptors, Fig. 1.
Molecules 1–3, 6 and 9 are linear diaza compounds with
rigidity imparted as a consequence of electronic and steric
factors. Compounds 4 and 10 can exhibit torsional flexibility
about the -bond between the two pyridyl rings. Dipyr-
idylethylene 5, diimine 7 and dipyridylethane 8 likewise
exhibit conformational flexibility. Trisimidazolyltriazine 11
contains six potential hydrogen-bond acceptors and consid-
erable torsional flexibility. These structurally and electro-
nically related compounds were subjected to the following
hydrate screening experiments: (i) crystallization from mixed
solvent systems; (ii) slurrying in water at ambient temperature;
(iii) exposure of anhydrous powders to humid conditions; (iv)
solvent drop grinding (SDG). The hydrate screening experi-
ments are collated in Table 2 and presented as a flowchart in
Fig. S2.
Crystallization from mixed solvent systems afforded eight
new single-crystal structures of which four are hydrates
(compounds 6, 7, 10 and 11, as shown in Figs. 1 and 2). Method
(i) therefore afforded hydrates at a greater frequency than
suggested by our CSD survey. Further details and analyses of
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the crystal structures are provided in the following section and
in the supporting information.
Slurry experiments using water or water/organic solvent
mixtures have previously been used to screen for the existence
of hydrates (Cui & Yao, 2008; Ticehurst et al., 2002). Beginning
with pure water, slurries of 1–11 were performed under
ambient conditions. PXRD and thermogravimetric analyses
(TGA) were used to determine that hydrates were isolated for
4–11. To examine the relative stability of the isolated hydrates,
the anhydrous and hydrated forms in 1:1 w/w ratios were
slurried in mixed solvent systems with varying ratios of EtOH
and H2O. The presence of water in
a solvent mixture in a fivefold
excess of EtOH invariably afforded
hydrates, see the supporting infor-
mation.
Standard accelerated stability
testing conditions as required in the
pharmaceutical industry (40C and
75% relative humidity (R.H.))
(Huynh-Ba, 2008) were employed
for 2–11. Pyrazine (1) was not
subjected to these conditions as it
sublimes under ambient conditions.
4,40-Dipyridyl (4) was studied first
since both the anhydrous and
hydrated forms of 4 were
previously reported (Boag et al.,
1999; Na¨ther et al., 2001). We observed a gradual transition of
the anhydrous form into the hydrated form over a period of
7 d as determined by PXRD, Fig. S18. Anhydrous forms of the
remaining compounds were subsequently exposed to 75%
R.H. at 40C for a minimum of 7 d, or until complete
conversion had occurred. Hydrates of 4–11 were isolated
under these conditions and their PXRD patterns were found
to match those from the slurry experiments. The presence of
water in the samples obtained from humidity exposure was
verified by PXRD and weight loss corresponding to the
appropriate amount of water in TGA (supporting informa-
tion).
Anhydrous variants of 1–11 were
also subjected to aqueous solvent
drop grinding (Karki et al., 2007;
Shah & Amidon, 2014) (method
iv). 1–3 did not form a hydrate after
mild hand grinding for 30 min. 4
and 8 were isolated as dihydrate
and anhydrate, respectively (Figs.
S16 and S32). Other compounds
were isolated as mixtures of both
forms (supporting information).
Solvent-drop grinding experiments
with pyrazine 1 could not be
performed as it sublimes at room
temperature.
To gauge the stability of the
hydrates of 4–8, 10 and 11, the
samples were exposed to ambient
laboratory conditions. PXRD
studies revealed that the hydrates
of 4, 6 and 11 were found to be
stable for 30 d, whereas those of 7,
8 and 10 converted to anhydrous
forms within 1 d. The hydrate
of 5 retained its stability for
10 d, but it started to convert
to its anhydrous form within
30 d.
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Figure 2
New crystal structures of (a)–(d) anhydrous and (e)–(h) hydrated forms of N-heterocyclic aromatics 1–
(11). (i)–(k) Water molecules organize into (i) one-dimensional infinite chains (C2) in 62H2O and
112H2O, (j) discrete rings (R4) in 74H2O, and (k) pentagonal (T5(2)) and hexagonal infinite tapes
(T6(1)) in 113H2O.
Table 2
Results of hydrate screening experiments that afforded anhydrous (A) and/or hydrated (H) forms.
Compound Slurry in H2O 75% R.H./40
C Competitive slurry SDG† Hydrate stability in air
1 A A – A –
2 A A – A –
3 A A – A –
4 H H H H > 30 d
5 H H H A + H 10 d < H < 30 d
6 H H H A + H > 30 d
7 H H H A + H < 1 d
8 H H H A < 1 d
9‡ H H H – –
10 H H H A + H < 1 d
11 H H H A + H > 30 d
† For compounds 1–3, SDG was performed for 30 min each. ‡ Experiments to determine the stability of the hydrate of 9
were not performed due to the similarity of the powder patterns of the hydrated and the anhydrous forms.
The thermal stability of hydrates of 4–7, 10 and 11 was
evaluated by TGA (supporting information). The temperature
at which water is lost was analyzed and compared with
structural attributes such as type of hydrate (channel or
isolated site hydrate), number of hydrogen-bond donors and
acceptors and hydrogen-bond distances to determine any
correlation. For 5H2O, an isolated site hydrate, the loss of
water occurs above 100C, suggesting that water molecules are
tightly bound. For 74H2O, water loss occurred below 100C.
For those channel hydrates in which water molecules are
organized into one-dimensional chains (42H2O, 62H2O and
102H2O) and tapes (113H2O), loss of water was observed to
occur below 100C. These observations are consistent with our
previous findings concerning structure/stability of cocrystal
hydrates (Clarke et al., 2010).
Overall, the hydrate screening experiments revealed that 8
out of 11 (72.7%) of the molecules studied form hydrates, a
much greater propensity than suggested by our CSD survey.
Slurrying anhydrous forms in water under ambient conditions
was the most effective method to isolate hydrates (4–11).
3.3. Analysis of water clusters
The hydrogen-bond environments of water molecules were
analyzed in the 23 hydrates obtained from our CSD analysis
(hitlist 7) and the seven hydrates isolated herein (Fig. 3). In
both subsets, water molecules tend to exhibit two hydrogen-
bond donors and one hydrogen-bond acceptor, which is
consistent with previous findings (Infantes et al., 2007). Crystal
structure analysis reveals no disorder and no particularly
significant thermal motion for the water O atoms at the
experimental temperature as judged by their thermal displa-
cement parameters. The stoichiometry of water in the crystal
lattice seems to affect what water clusters or hydrogen-bond
patterns are present in these subsets. Infantes et al. have
classified water clusters as discrete rings and chains, infinite
chains and tapes and layer structures and assigned the symbols
R, D, C, T and L, respectively. These symbols were further
refined by suffix ‘n’, specifying the number of water molecules
forming the repeat unit. For example, ‘C2’ means the water
molecules form one-dimensional infinite chains, and n = 2
signifies two water molecules form the unit cell repeat unit of
the chain or one crystallographically independent water
molecule is repeated by a C2-screw axis, Fig. 2(i). The authors
also calculated the frequency of occurrence of each of these
water clusters in crystal structures reported in the CSD
(Infantes & Motherwell, 2002; Infantes et al., 2003). We have
adopted this nomenclature herein. In general, dihydrates
occur for dipyridyls whereas trihydrates tend to be formed by
tripyridyls. Out of the 23 hydrates in hitlist 7, six are dihydrates
and five of these contain C2 chains. Six of the 23 hydrates are
trihydrates but their water clusters vary. Only one entry is a
tetrahydrate with a T4(2) water cluster. If we include 1–11, the
number of dihydrates increases to eight (62H2O and
102H2O) and 7/8 contain C2 chains, Fig. 2(i). The stoichio-
metry as determined from TGA and Karl Fisher titration
experiments conducted upon the hydrates of 8 and 9 is
inconsistent with dihydrates (supporting information). This
might be attributed to conformational flexibility and torsional
rigidity in 8 and 9, respectively. As a result, assembly into C2
chains, which requires molecules to be in close proximity to
each other, is hindered. The number of tri- and tetrahydrates
increases by one each because of 113H2O and 74H2O,
respectively. 113H2O exhibits infinite pentagonal (T5(2)) and
hexagonal (T6(1)) tapes (Fig. 2k), whereas 74H2O forms R4
clusters (Fig. 2j). We note that association of water molecules
into one-dimensional chains and/or tapes facilitates N-
heterocyclics to further associate through 
–
 (face-to-face)
interactions (Table S1). As a result, O—H  N and 
–
 (face-
to-face) interactions are dominant in their crystal packing.
3.4. Computational studies
The results of the hydrate screening experiments reported
herein indicate that molecules with similar functionality can
behave quite differently with respect to hydrate formation.
This is unsurprising given previous studies upon hydrates and
begs the following question: what makes 1–3 behave differ-
ently than 4–11? The molecular electrostatic potential has
been shown to serve as an effective tool for correlating with
and even predicting molecular interactions and crystal beha-
viour (Scrocco & Tomasi, 1978; Politzer & Daiker, 1981;
Politzer & Murray, 1991). Politzer and co-workers have shown
that the ability of a solute molecule to accept or donate a
proton in solution (solvatochromic hydrogen-bond donor and
acceptor parameters) can be correlated with its calculated
electrostatic potential, which pertains to the molecule in its gas
phase (Murray et al., 1991; Murray & Politzer, 1991). Later,
Galabov et al. (2003) have also shown that there exist excellent
linear relationships between molecular electrostatic potentials
of the nuclei participating in hydrogen bonding and the
binding energies. These studies exemplify that calculated
electrostatic potential can be used as an indicator to predict
the hydrate propensity in certain types of molecules. Elec-
trostatic potentials were calculated for 1–11 and mapped on
the molecular electron density surfaces (Fig. 4) in an attempt
to correlate electrostatic potential at the nitrogen atom with
propensity for hydrate formation. 1 is an outlier since its
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Figure 3
Patterns in which water molecules are hydrogen bonded to water (W)
and/or N-heterocyclic rings (N) in (a) the 23 structures retrieved from the
CSD search and (b) 7 structures included for screening experiments.
nitrogen atoms are calculated to have a much lower electro-
static potential energy (158 kJ mol1) than 2–11 ( ca.
180 kJ mol1). This relatively weak negative electrostatic
potential implies that 1 would not be as strong a hydrogen-
bond acceptor for water than 2–11. However, molecules 2 and
3 do not form hydrates and are not outliers with negative
potentials of 176 and 185 kJ mol1, respectively.
3.5. Crystal packing analysis
In order to address why 2 and 3 do not form hydrates as
readily as 4–11, we analyzed the crystal packing exhibited by
1–11. There is a significant difference between the anhydrates
and the hydrates. In the anhydrates, multiple weak C—H  

(edge-to-face, DC  C = 3.53–3.79 A˚) and/or C—H  N (DC  N
= 3.38–3.60 A˚) interactions are responsible for controlling the
crystal packing (Table S1). In the crystal structures of the
hydrates, crystal packing tends to be directed by strong
hydrogen bonds between water molecules (O—H  O with
DO  O = 2.74–2.86 A˚) and between water molecules and basic
nitrogen atoms (O—H  N with DO  O = 2.82–2.98 A˚). As
mentioned earlier, for di- and trihydrates, in which one-
dimensional water motifs are usually observed, water aggre-
gation leads to the organization of organic molecules in such a
manner that enables 
–
 stacking interactions (face-to-face,
DC  C = 3.44–3.91 A˚). Thus, in the crystal structure of these
hydrates, strong O—H  O and O—H  N hydrogen bonds
are present along with 
–
 stacking interactions. The inter-
molecular interactions observed in the crystal structures of the
hydrates and anhydrates are collected in Table S1.
It has been reported that aromatic rings prefer to adopt
edge-to-face or T-shaped geometry over face-to-face or
parallel geometry (Hunter, 1994; Nishio, 2004). The crystal
structures of both hydrate and anhydrate forms were deter-
mined for 4–7. 7  C—H  N (DC  N = 3.38–3.60 A˚)
hydrogen bonds surround each molecule of 4 in its anhydrous
form, whereas in the 42H2O 4  O—H  O (DO  O = 2.74–
2.75 A˚), 2O—H  N (DO  N = 2.83–2.87 A˚), 3 C—H  O
(DC  O = 3.40–3.55 A˚), 4  C—H  N (DC  N = 3.38–3.60 A˚)
hydrogen bonds and 4  
–
 stacking interactions (face-to-
face, DC  C = 3.70–3.74 A˚) are present. It is therefore unsur-
prising that 4 readily forms a dihydrate when subjected to our
screening experiments. A comparison of intermolecular
interactions in the anhydrous forms of 1–9 reveals that in 2–3,
for which hydrates do not yet exist, a greater number of C—
H  N and/or C—H  
 stacking interactions are observed.
For example, there are more C—H  N (8  DC  N = 3.41 A˚)
and C—H  
 (8  DC  C = 3.79 A˚) interactions in 3 than in
4–6 (Fig. 5b, Table S1). The propensity of 2 and 3 to exist as
anhydrates might therefore be attributed to the large number
of weak interactions they exhibit that would be lost in the
corresponding hydrates.
4. Conclusion
In this study we have investigated the propensity for hydrate
formation of five- and six-membered N-heterocyclic aromatic
compounds that are devoid of strong hydrogen-bond donors.
Our investigation involving a CSD survey, systematic hydrate
screening experiments, analyses of electrostatic potential
maps and crystal packing patterns has led to the following
conclusions:
CSD statistics tend to understate the propensity for hydrate
formation when compared to systematic experimental
screening that includes exposure to humidity and slurrying in
water.
When hydrates are not afforded by systematic experimental
screening, analysis of ESP maps and crystal packing in
anhydrates can provide insight into why this is the case.
It would be inappropriate to extrapolate beyond the specific
subset of molecular compounds studied herein, but systematic
experimental studies on other subsets of molecular
compounds are expected to provide insight into their
propensity towards formation of
crystalline hydrates.
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